Brief: Active Biotech: Safety And Ocular Biodistribution Support Development Of Laquinimod Eye Drops For Inflammatory Eye Disorders
30/05/2023 11:45
May 30 (Reuters) - Active Biotech AB publ ACTI.ST :
* SAFETY AND OCULAR BIODISTRIBUTION SUPPORT DEVELOPMENT OF
LAQUINIMOD EYE DROPS FOR INFLAMMATORY EYE DISORDERS
* DATA FROM RECENTLY COMPLETED PHASE I STUDY WITH EYE DROP
FORMULATION OF LAQUINIMOD WILL BE PRESENTED IN A POSTER SESSION
AT INTERNATIONAL OCULAR INFLAMMATION SOCIETY (IOIS) 2023 MEETING
IN BERLIN
* LAQUINIMOD WAS DEMONSTRATED TO BE SAFE AND TOLERABLE
Source text for Eikon: ID:nMFN9gV9vH
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))